Ranbaxy Laboratories has commenced exports of Atorvastatin Calcium Oral Tablets to the US market, from its Mohali SEZ manufacturing facility, located in Punjab, India. The first consignment of Atorvastatin Tablets has been dispatched to the US market in March 2012. The supply of Atrovastatin tablets from India supplements the company’s current production from Ohm Laboratories Inc, USA.
Ranbaxy’s dosage facility at Mohali was approved by the US Food and Drug Administration (USFDA) in October 2011. Thereafter, in the first quarter of 2012, the company received approval from the USFDA to manufacture and market Atorvastatin 10mg, 20mg, 40mg and 80mg tablets. Earlier, international regulatory authorities such as the WHO-Geneva, National Medicine and Medical Devices Agency (NMMDA) - Romania, ANVISA- Brazil, TGA- Australia, Canada Health-Canada etc. had also approved the company's Mohali facility.
The new facility at Mohali will manufacture oral solid products for export to US, EU and other countries based on filings and after receiving the necessary approvals. It is equipped with the latest state-of-the-art technology, designed to meet global and local regulatory requirement and conforms to cGMP standards.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.05 |
| Dr. Reddys Labs. | 1275.30 |
| Cipla | 1441.10 |
| Zydus Lifesciences | 1152.75 |
| Lupin | 2511.75 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: